Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

M6A modification in cisplatin-resistant cells

ABSTRACT: m6A modification in cisplatin-resistant cells

PROVIDER: PRJNA588053 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10407537.fastq.gz	Fastqsanger.gz
	SRR10407538.fastq.gz	Fastqsanger.gz
	SRR10407539.fastq.gz	Fastqsanger.gz
	SRR10407540.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

m6A modification in cisplatin-resistant cells

Project description:We report the application of specific antibodies and high-throughput sequencing technologies (methylated RNA immunoprecipitation sequencing, MeRIP-seq) for high-throughput profiling of m6A modifications in NSCLC cisplatin resistant cells. We generated maps of m6A modified transcripts in A549 and A549/DDP cells. We find that the m6A level was significantly increased in A549/DDP cells compared to the A549 cells. We show that there was a close correlation between the m6A modification and cisplatin resistance.

2022-11-04 | GSE140020 | GEO

m6A modification in Herceptin resistant cells [MeRIP-Seq]

Project description:m6A modification in Herceptin resistant cells [MeRIP-Seq]

| PRJNA781739 | ENA

m6A modification in Herceptin resistant cells [MeRIP-Seq]

Project description:We report the application of specific antibodies and high-throughput sequencing technologies (methylated RNA immunoprecipitation sequencing, MeRIP-seq) for high-throughput profiling of m6A modifications in breast cancer herceptin resistant cells. We generated maps of m6A modified transcripts in BT474 and BT474.TtzmR cells. We find that the m6A level was significantly increased in BT474.TtzmR cells compared to the BT474 cells. We show that there was a close correlation between the m6A modification and herceptin resistance.

2024-11-18 | GSE189160 | GEO

m6A RNA modification controls cell fate transition in mammalian embryonic stem cells

Project description:N6-methyl-adenosine (m6A) is the most abundant modification on messenger RNAs and is linked to human diseases, but its functions in mammalian development are poorly understood. Here we reveal the evolutionary conservation and function of m6A by mapping the m6A methylome in mouse and human embryonic stem cells. Thousands of messenger and long noncoding RNAs show conserved m6A modification, including transcripts encoding core pluripotency transcription factors. m6A is enriched over 3M-bM-^@M-^Y untranslated regions at defined sequence motifs, and marks unstable transcripts, including transcripts turned over upon differentiation. Genetic inactivation or depletion of mouse and human Mettl3, one of the m6A methylases, led to m6A erasure on select target genes, prolonged Nanog expression upon differentiation, and impaired ESCM-bM-^@M-^Ys exit from self-renewal towards differentiation into several lineages in vitro and in vivo. Thus, m6A is a mark of transcriptome flexibility required for stem cells to differentiate to specific lineages. Examing m6A modification differences in two different cell types

2014-10-20 | E-GEOD-52600 | biostudies-arrayexpress

m6A RNA modification controls cell fate transition in mammalian embryonic stem cells (RNA methylation)

Project description:Here we determine the map of RNA methylation (m6A) in mouse embrionic stem cells, and Mettl3 knock out cells Examination of m6A modification sites on the transcriptome of mouse Embryonic stem cells and Embryonic Mettl3 knock out cells, using a m6A specific antibody.

2014-10-16 | E-GEOD-52662 | biostudies-arrayexpress

m6A modification profile in primary microglia with/without Igf2bp1 knockdown

Project description:Our study demonstrated that the expression of Igf2bp1 in activated microglia was significantly up-regulated, implying a role of Igf2bp1 in LPS-induced m6A modifications in microglia. To understand the roles of Igf2bp1 on LPS-induced m6A modification in microglia, we performed Igf2bp1 loss-of-function (LOF) approach. Microglia stimulated by LPS were transfected with either scrambled siRNA control or Igf2bp1 siRNA for 48 hours. To m6A modification profiles in control and Igf2bp1 LOF microglia were determined by MeRIP-seq analysis.

2022-12-31 | E-MTAB-11411 | biostudies-arrayexpress

m6A modification in effector CD4+ T cells [m6A-miCLIP-seq]

Project description:m6A modification in effector CD4+ T cells [m6A-miCLIP-seq]

| PRJNA532394 | ENA

MicroRNA profiling of cisplatin-resistant and cisplatin-sensitive ovarian cancer cells

Project description:MicroRNA profiling of cisplatin-resistant and cisplatin-sensitive ovarian cancer cells

| PRJNA679457 | ENA

m6A modification in DP and iNKT cells

Project description:m6A modification in DP and iNKT cells

| PRJNA865276 | ENA

Gene expression profile in cisplatin-resistant lung cancer cells

Project description:Gene expression profile in parental and cisplatin-resistant A549 cells